Evidence map›Paper›PMID 33227945›Full record

ArticleBiomolecules2020

Identification and Validation of Carbonic Anhydrase II as the First Target of the Anti-Inflammatory Drug Actarit.

Ghita Ghislat, Taufiq Rahman, Pedro J Ballester

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Artificial Intelligence-Guided Phenotypic Drug Repurposing Against Streptococcus pneumoniae.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ghita GhislatCentre d'Immunologie de Marseille-Luminy, Inserm, U1104, CNRS UMR7280, F-13288 Marseille, France.
Taufiq RahmanDepartment of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK.ORCID 0000-0003-3830-5160
Pedro J BallesterCentre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, F-13009 Marseille, France.
Centre National de la Recherche Scientifique · FRUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Proof of Concept StudyAnti-Inflammatory AgentsAntirheumatic AgentsArthritis, RheumatoidCarbonic Anhydrase IIDose-Response Relationship, DrugDrug Delivery SystemsHumansPhenylacetatesReproducibility of Results4-(acetylamino)benzeneacetic acidAnti-Inflammatory AgentsAntirheumatic AgentsCarbonic Anhydrase IIPhenylacetatesactaritcarbonic anhydrase IImalotilateMolTarPredtarget prediction

Identifiers

PMID33227945
PMCPMC7699199
OpenAlexW3102043580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.